Instructions about nicotine dose influence acute responses to nasal spray

Nicotine and Tobacco Research

Volumn 6, Issue 6, 2004, Pages 1051-1060

  Perkins, Kenneth A ^a   Jacobs, Lynette ^a   Clark, Lindsey ^a   Conklin, Cynthia A ^a   Sayette, Michael ^a   Wilson, Annette ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; AEROSOL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG SELF ADMINISTRATION; DRUG USE; FEE; FEMALE; FREQUENCY ANALYSIS; HEART RATE; HUMAN; INTERMETHOD COMPARISON; MALE; MOOD; PATIENT EDUCATION; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REINFORCEMENT; REST; REWARD; SELF REPORT; SMOKING; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; WITHDRAWAL SYNDROME;

ADMINISTRATION, INTRANASAL; ADULT; AFFECT; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; IMPULSIVE BEHAVIOR; MALE; NICOTINE; QUESTIONNAIRES; REINFORCEMENT (PSYCHOLOGY); SMOKING; SMOKING CESSATION; TEACHING;

EID: 12344290512     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200412331324857     Document Type: Article

References (22)

1. Behm, F. M., & Rose, J. E. (1994). Reducing craving for cigarettes while decreasing smoke intake using capsaicin-enhanced low tar cigarettes. Experimental and Clinical Psychopharmacology, 2, 143-153.
2. Carter, B. L., & Tiffany, S. T. (2001). The cue-availability paradigm: The effects of cigarette availability on cue reactivity in smokers. Experimental and Clinical Psychopharmacology, 9, 183-190.
3. Gottlieb, A. M., Killen, J. D., Marlatt, G. A., & Taylor, C. B. (1987). Psychological and pharmacological influences in cigarette smoking withdrawal: Effects of nicotine gum and expectancy on smoking withdrawal symptoms and relapse. Journal of Consulting and Clinical Psychology, 55, 606-608.
4. Gourlay, S. G., & Benowitz, N. L. (1997). Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clinical Pharmacology and Therapeutics, 62, 453-463.
5. Griffiths, R. R., Rush, C. R., & Puhala, K. A. (1996). Validation of the multiple-choice procedure for investigating drug reinforcement in humans. Experimental and Clinical Psychopharmacology, 4, 97-106.
6. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K.-O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
7. Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289-294.
8. Hughes, J. R., Pickens, R. W., Spring, W., & Keenan, R. M. (1985). Instructions control whether nicotine will serve as a reinforcer. Journal of Pharmacology and Experimental Therapeutics, 235, 106-112.
9. Juliano, L. M., & Brandon, T. H. (2002). Effects of nicotine dose, instructional set, and outcome expectancies on the subjective effects of smoking in the presence of a stressor. Journal of Abnormal Psychology, 111, 88-97.
10. Kalman, D. (2002). The subjective effects of nicotine: Methodological issues, a review of experimental studies, and recommendations for future research. Nicotine & Tobacco Research, 4 25-70.
11. Kirsch, I. (1997). Specifying nonspecifics: Psychological mechanisms of placebo effects. In A. Harrington (Ed.), The placebo effect: An interdisciplinary exploration (pp. 166-186). Cambridge, MA: Harvard University Press.
12. Marlatt, G. A., Demming, B., & Reid, J. B. (1973). Loss of control drinking in alcoholics: An experimental analogue. Journal of Abnormal Psychology, 81, 233-241.
13. Marlatt, G. A., & Rohsenow, D. J. (1980). Cognitive processes in alcohol use: Expectancy and the balanced placebo design. In N. K. Mello (Ed.), Advances in substance abuse: Behavioral and biological research, Vol. 1 (pp. 159-199). Greenwich, CT: JAI Press.
14. Martin, C. S., & Sayette, M. A. (1993). Experimental design in alcohol administration research: Limitations and alternatives in the manipulation of dosage-set. Journal of Studies on Alcohol, 54, 750-761.
15. Perkins, K. A., Fonte, C., Sanders, M., Meeker, J., & Wilson, A. (2001a). Threshold doses for nicotine discrimination in smokers and nonsmokers. Psychopharmacology, 155, 163-171.
16. Perkins, K. A., Gerlach, D., Broge, M., Sanders, M., Grobe, J. E., Fonte, C., Cherry, C., & Wilson, A. (2001b). Quitting smoking produces minimal loss of chronic tolerance to nicotine. Psychopharmacology, 158, 7-17.
17. Perkins, K. A., Grobe, J. E., D'Amico, D., Fonte, C., Wilson, A., & Stiller, R. L. (1996). Low-dose nicotine nasal spray use and effects during initial smoking cessation. Experimental and Clinical Psychopharmacology, 4, 157-165.
18. Perkins, K. A., Jetton, C., & Keenan, J. (2003a). Common factors across subjective effects of nicotine. Nicotine & Tobacco Research, 5, 869-875.
19. Perkins, K. A., Sayette, M., Conklin, C. A., & Caggiula, A. R. (2003b). Placebo effects of tobacco smoking and other nicotine intake. Nicotine & Tobacco Research, 5, 695-709.
20. Siegel, S. (2002). Explanatory mechanisms for placebo effects: Pavlovian conditioning. In H. A. Guess, A. Kleinman, J. W. Kusek, & L. W. Engel (Eds.), The science of the placebo (pp. 133-157). London: BMJ Books.
21. Tate, J. C., Stanton, A. L., Green, S. B., Schmitz, J. M., Le, T., & Marshall, B. (1994). Experimental analysis of the role of expectancy in nicotine withdrawal. Psychology of Addictive Behaviors, 8, 169-178.
22. Tiffany, S. T., & Drobes, D. J. (1991). The development and initial validation of a questionnaire of smoking urges. British Journal of Addiction, 86, 1467-1476.